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A B S T R A C T
Mood disorders are a leading cause of the burden of disease in youth. Three critical lessons emerge from the
reviews in this issue that are relevant to our understanding of these commonmental disorders: ﬁrst, that the
brain is in a highly dynamic stage of its development during youth; second, that environmental factors
interactwith genetic factors to inﬂuence theprobability of risk behaviors anddysphoric states; and third, that
shared developmental and genetic factorsmay account for the bulk of emotional and behavioral outcomes in
youth, and that environmental inﬂuences may affect the speciﬁc expression of the phenotypes associated
with these pathways. Although this evidence does not immediately indicate the potential for new interven-
tions, it is consistent with current policy and practice recommendations. Interventions should focus on both
improving the early detection andmanagement of depressive disorders as well as preventive strategies that
aim to train children and youth to improve cognitive control and manage stress more effectively. Limiting
access to harmful risk-taking situations and providing opportunities to engage are less harmful, but equally
exciting, alternatives in a pragmatic universal prevention policy option. Key research priorities and para-
digms emerge from this evidence, particularly in the context of the grand challenges in global mental health. 2013 Society for Adolescent Health and Medicine.
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Open access under CC BY-NC-ND license.Mental disorders, such as mood disorders, substance use dis-
rders, and psychoses, are the leading cause of ill health in
dolescents and young people (referred to as “youth” in this
rticle) globally, including in low- and middle-income countries
LMIC) [1]. Even in sub-Saharan Africa where HIV remains a
ajor cause of ill health in this demographic group, mental
isorders are the leading noncommunicable cause of disease
urden. Additionally, mental disorders underlie a substantial
roportion of suicides, a leading cause of death in youth [2].
part from causing enormous suffering in youth, the majority of
ental disorders seen in adults have their onset in youth. Thus,
outh may represent the most important demographic window
or interventions to reduce the burden ofmental disorders across
he life span. This article will principally address mood disorders
ecause these contribute the most to the burden of disease.
lthough not explicitly addressed, some of the policy and prac-
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Open access under CC BY-NCice considerations raised in this article apply to other disorders
s well. Substance use disorders are also addressed in another
rticle in this issue [3].
The terms “mood disorder” and “depressive disorder” tend to
e used interchangeably; furthermore, the term “depression” is
sed both to indicate an emotional state and a mental disorder.
lthough transient situational depression is a common emo-
ional state among youth, the persistent disruption of affect
haracteristic of depressive disorder, is less common. Although
are before puberty, the prevalence of depressive disorder in-
reases dramatically after puberty, with a notable gender gap—
omen are between 1.5 and 2 timesmore likely to be diagnosed,
gap that persists through the life course. A major challenge is
istinguishing the point when feelings of sadness and losing
nterest, along with their behavioral and physical features (such
s sleep problems, tiredness, loss of appetite, aches and pains in
arious areas of the body, and so on), become a “disorder.” Cur-
ent classiﬁcations of mental disorder rely on the number, dura-
ion, and impact of these experiences tomake this distinction [4].
his method, while being inevitably arbitrary, remains the only
-ND license.
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research reviewed in this issue, we remain a long way from a
valid and replicable biomarker of this disorder.
Current Recommendations
Youth is a critical period in an individual’s life when he/she
establishes personal identity, completes education, gets a job,
and establishes romantic partnerships. A depressive disorder can
derail that trajectory. Despite the rich evidence base on the
epidemiology of depressive disorder in youth, we know compar-
atively less about its causes and treatment. The evidence in
support of antidepressant medication is equivocal [1]; in con-
trast, the evidence pointing to the beneﬁcial effects of brief struc-
tured psychological treatments is more robust, including trials
from LMIC [5,6]. One notable addition to this rule is the Treat-
ment for Adolescents with Depression Study [7], which reported
that a combination treatment using an antidepressant (ﬂuox-
etine) and psychological treatment (cognitive-behavioral ther-
apy) was superior to either treatment alone.
In general, current guidelines, including the latest World
Health Organization guidelines for the treatment of mental dis-
orders in general health care settings, advocate the use of psy-
chological treatments as the ﬁrst line of treatment for depressive
disorder in youth, with judicious use of ﬂuoxetine reserved for
nonresponders [8]. Amajor barrier to delivering such treatments
s the lack of skilled mental health human resources and youth
ental health services globally. A key strategy to address these
arriers is task sharing of speciﬁc mental health interventions
e.g., a speciﬁc psychological treatment) to lay and community
ealth workers in collaboration with specialists. Such models of
are have been shown to be extremely effective in improving
ecovery rates in trials in LMIC [9]. There is modest evidence
upporting preventive interventions to reduce depressive symp-
oms in children and youth; these are often school based, target
hose who have subclinical symptoms, and comprise a range of
trategies, from programs targeting competence training and
ocial and coping skills to more speciﬁc preventive strategies for
epression, such as cognitive restructuring [10]. One example of
n extensively evaluated intervention is the Penn Resiliency Pro-
ram that aims to change cognitive distortions and to improve
oping skills in children with depressive symptoms; it remains
ne of the few preventive interventions to have been evaluated
n an LMIC [11].
Lessons From Neuroscience and Genetics
Three critical lessons emerge from the reviews of this issue:
ﬁrst, that far from being a relatively static organ, the brain is in a
highly dynamic stage of its development during youth; second,
that environmental factors interact with genetic factors to in-
crease, or decrease, the probability of risk behaviors and dys-
phoric states; and third, that shared developmental and genetic
factors may account for the bulk of emotional and behavioral
outcomes in youth, and that environmental inﬂuences (such as
gender roles) may inﬂuence the speciﬁc expression of the phe-
notypes associated with these pathways. The dynamic state of
the brain is exempliﬁed by the evidence that synaptic pruning is
“highly speciﬁc and pronounced” during youth, and this is essen-
tial for the “rewiring of the brain into the typical adult pattern.”
Myelination “escalates, speeding information ﬂow andmagnify-
ing its impact” (Spear). There is delayed maturation of the pre-frontal and other frontal regions, which are responsible for the
control of subcortical regions; this is associated with immature
cognitive control, attentional regulation, response inhibition,
and other advanced cognitive functions. There are notable differ-
ences in the response of the brain to stimuli in youth and adults;
for example, youth brains appear to be less harm avoidant be-
cause neural responses to negative feedback may mature later.
Rational decision making appears to reach adult levels by mid-
adolescence, but this capacity is reduced under emotionally
charged circumstances, a phenomenon called “hot cognitions”
(Spear); interestingly, it appears that environmental inﬂuences,
such as social peers, seem to be particularly effective in inducing
“hot cognitions,” and such states may also be related to an in-
creased risk of using drugs (Potenza). Althoughmost evidence in
support of plasticity is fromanimal research, there is good reason
to believe that the brain does respond through anatomical
changes in response to environmental stimuli well into adult-
hood; thus, some synaptic pruning and the formation of new
neurons in speciﬁc brain regions may be experience dependent.
Genetic research also offers an opportunity to better understand
the etiology of depressive disorders. However, at best, the heri-
tability of mood disorders does not exceed 40%; this clearly
indicates the strong role of environmental factors, both biologi-
cal (such as hormonal changes associated with puberty) and
social (such as gender roles), in explaining individual differences
in the risk of depression.
Implications for Programs and Policies
A range of terms, such as volatile, temperamental, moody, or
irritable, has been used to characterize the typical pattern of
mood and behavior of adolescents and youth. All of them suggest
that emotional dysregulation is characteristic of this period of
the life course. The evidence reviewed in this issue greatly con-
tributes to our understanding of the basis of such dysregulation
and, potentially, the etiology of mood disorders. Put simply,
youth “moodiness” may be best understood as a natural accom-
paniment of neurodevelopment that can be profoundly modu-
lated, in both enabling and damagingways, by a range of internal
and external environmental factors. Some degree of sensation
seeking and risk taking is normative, rational, and even, onemay
argue, an evolutionary imperative. After all, are not the learning
tasks essential for adulthood reinforced by taking risks? The
most important policy imperative is to identify how these essen-
tial normative tasks can be completed successfully in the rapidly
changing environments facing the adolescent brain, rather than
emphasizing their control or suppression. Furthermore, the ap-
parent comorbidity of many youth risk behaviors may be ex-
plained by their shared genetic andneurodevelopmental origins;
differential phenotypic expression may be the result of environ-
mental inﬂuences. The curious gender differences observed in
the form of higher risk of mood disorders in young women and
the higher risk of addictive disorders in young men may well be
due to such interactions.
Having said this, there are many unanswered questions re-
garding the nature of brain development and other biological
changes during youth and how they interact with the environ-
ment to inﬂuence the risk and course of depressive disorders. The
road toward translating exciting discoveries in genetics and neu-
roscience into practical interventions is still a long and uncertain
one. In particular, the prospect of answering these questions
remains hampered by the lack of a deﬁnitive biomarker or endo-
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(Potenza), for mood disorders. These have been recognized
among the grand challenges to address the global burden of
mental disorders [12]. Advanced methods to investigate brain
functioning, for, example, neuroimaging, may offer a new ap-
proach for the detection of youth at risk of developing a depres-
sive disorder; such techniques may also be useful to investigate
the biological impact of evidence-based treatments and to help
develop treatments that can more effectively target the biologi-
cal processes that predispose to high-risk behaviors. However, it
is equally important to investigate the environmental factors
that contribute toward resiliency; even thoughmental disorders
are a leading cause of the burden of disease, most youth, includ-
ing those who live in circumstances of great disadvantage in
low-resource countries, are in good mental health [13]. Factors
such as peer relationships, parenting practices, and educational
attainment are critically important determinants of mental
health, and future research should elaborate the role of these
factors in inﬂuencing risk and gene expressions. It is also impor-
tant to recognize that there has been almost no research from
LMIC that can contribute to the necessary knowledge, and it is
unlikely that gene/neurodevelopment–environmental interac-
tionswill be illuminated by researching only a tiny fraction of the
global population.
In the context of the evidence reviewed in this issue, it is not
possible tomake any deﬁnitive recommendations for new inter-
ventions. However, the evidence base is consistent with current
policy and practice recommendations. During youth itself, inter-
ventions should focus on both improving the early detection and
management of depressive disorders based on existing evidence
derived from clinical research. Preventive strategies that aim to
train children and youth to improve cognitive control and man-
age stress more effectively may help reduce the propensity for
“hot cognition.” Such interventions should be provided in youth-
friendly settings, including schools. Limiting access to harmful
risk-taking situations and providing opportunities to engage are
less harmful, but equally exciting, alternatives in a pragmatic
universal prevention policy option. In addition, it is time to
move from an outcome-based approach to researching etiol-
ogy to examining how shared genetic predispositions and
neurodevelopmental trajectories interact with environmental
factors to lead to differential phenotypes of dysphoria and riskbehaviors in youth. To achieve this ambitious goal, we need to
establish large population-based cohorts of young children,
with explicit interdisciplinary leadership, in diverse sociocul-
tural contexts. Only then will the promise that an integrative
framework of genetics, neurodevelopment, and environment
can deliver tangible goods to reduce the burden of mental
disorders become a reality.
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